Related Experiment Videos

Urinary DKK3 as a predictor of CKD stages in reflux nephropathy in children

Ayşe Seda Pinarbaşi1, Neslihan Günay2, İnayet Güntürk3

  • 1Division of Pediatric Nephrology, Department of Pediatrics, Eskişehir Yunus Emre State Hospital, Eskişehir, Turkiye.

Insights

Urinary Dickkopf-3 (uDKK3) shows potential as a biomarker for advanced chronic kidney disease (CKD) in children with reflux nephropathy. Higher uDKK3 levels correlate with more severe CKD, but its role in early stages requires further investigation.

Area of Science:

  • Pediatric Nephrology
  • Biomarker Discovery
  • Chronic Kidney Disease (CKD)

Background:

  • Reflux nephropathy is a significant cause of pediatric CKD.
  • Early intervention is crucial for slowing CKD progression.
  • Urinary Dickkopf-3 (uDKK3) is a potential biomarker for tubulointerstitial fibrosis, with limited pediatric data.

Purpose of the Study:

  • To investigate the role of urinary Dickkopf-3 (uDKK3) levels in predicting CKD stage in children with reflux nephropathy.
  • To assess the association between uDKK3, estimated glomerular filtration rate (eGFR), and albuminuria.
  • To evaluate the diagnostic performance of uDKK3 for CKD severity.

Main Methods:

  • Cross-sectional study of 113 children with CKD stages 1-4 and 28 healthy controls.
  • Measurement of uDKK3 concentrations via enzyme-linked immunosorbent assay (ELISA).
  • Correlation analysis with eGFR and albuminuria; Receiver Operating Characteristic (ROC) curve analysis.

Main Results:

  • Significantly higher uDKK3 levels in advanced CKD stages (3-4) compared to early stages (1-2) and controls.
  • Strong negative correlation between uDKK3 and eGFR; positive correlation with albuminuria.
  • ROC analysis for uDKK3/urinary creatinine ratio (uDKK3/uCr) showed an AUC of 0.77, with 71.1% sensitivity and 71.4% specificity.

Conclusions:

  • The uDKK3/uCr ratio may serve as a noninvasive biomarker for assessing pediatric CKD severity in reflux nephropathy.
  • uDKK3 utility in identifying early-stage CKD was not clearly demonstrated.
  • Further large-scale prospective studies are needed to confirm the clinical applicability and prognostic value of uDKK3 in pediatric CKD.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...